CSS
BIOSU

Cubist Systematic Strategies’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Cubist Systematic Strategies’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-27,991
Closed -$286K – 4647
2022
Q4 		$286K Sell
27,991
-6,123
-18% -$62.2K ﹤0.01% 3391
2022
Q3 		$343K Buy
+34,114
New +$342K ﹤0.01% 3444
2022
Q1 		– Sell
-519,758
Closed -$5.2M – 3892
2021
Q4 		$5.2M Buy
+519,758
New +$5.21M 0.05% 623

Other funds holding BIOSU

HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Cubist Systematic Strategies's BIOSU Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q1 2023, closing a stake of 27,991 shares — an estimated $286K sold.

Cubist Systematic Strategies first reported a position in BIOSU in Q4 2021 and held it in 3 quarters. The position peaked at $5.2M in Q4 2021. 9 funds tracked by Wall St. Rank hold BIOSU as of Q1 2023.

  • Cubist Systematic Strategies reported no remaining BioPlus Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 27,991 BioPlus Acquisition Corp. Unit shares in Q1 2023, an estimated $286K.
  • Cubist Systematic Strategies first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 3 quarters.
  • Cubist Systematic Strategies's BioPlus Acquisition Corp. Unit position peaked at $5.2M in Q4 2021.
  • 9 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.